Does antiarrhythmic therapy prevent the development of atrial fibrillation in patients with hypertrophic cardiomyopathy?
Patients with hypertrophic cardiomyopathy (HCM)
Antiarrhythmic therapy
Development of atrial fibrillation (AF)hard clinical
Clinical parameters can identify HCM patients at risk for AF, which carries a poor prognosis and is not prevented by long-term antiarrhythmic therapy.
This study shows that patients with HCM who are at risk of AF development can be identified using readily available clinical parameters. The development of AF is associated with a poor prognosis but there was no evidence that antiarrhythmic therapy prevents AF in the long term.
Building similarity graph...
Analyzing shared references across papers
Loading...
Oliver Guttmann
Interventional Cardiology
Menelaos Pavlou
Royal Statistical Society
Constantinos O’Mahony
Interventional Cardiology
Heart
University College London
University of Bologna
National and Kapodistrian University of Athens
Building similarity graph...
Analyzing shared references across papers
Loading...
Guttmann et al. (Fri,) studied this question.
synapsesocial.com/papers/69c5e6dc7090fce65e4ad852 — DOI: https://doi.org/10.1136/heartjnl-2016-309672
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: